Pleural Mesothelioma
📧 Sign up to get email alerts when something new happens for Pleural Mesothelioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-03-15Clinical Trial Update: Diadem to Investigate the Activity and Safety of Durvalumab [Phase 2]
Phase 2 trial update investigating durvalumab activity and safety in pleural mesothelioma has completed.
-
CLINICAL_TRIALS trial_result · 2023-01-10Clinical Trial Update: TILs & Low-Dose IL-2 Therapy Following Cyclophosphamide and Fludarabine in Pleural Mesothelioma Patients [Phase 1, Phase 2]
Phase 1/2 trial evaluating tumor-infiltrating lymphocytes (TILs) and low-dose IL-2 after cyclophosphamide and fludarabine in pleural mesothe…
-
CLINICAL_TRIALS trial_result · 2021-10-14Clinical Trial Update: A Comparative Study Between Regional Anesthesia in Thoracoscopes and the Conventional General Anesthesia [Phase 4]
Phase 4 trial comparing regional anesthesia during thoracoscopy to conventional general anesthesia in pleural disease settings; status curre…
-
CLINICAL_TRIALS trial_result · 2021-04-14Clinical Trial Update: Study of Nivolumab Combined With Ipilimumab Versus Pemetrexed and Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma Patients [Phase 3]
A Phase 3 trial comparing nivolumab plus ipilimumab versus pemetrexed with cisplatin or carboplatin as first-line therapy in unresectable pl…
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma [Phase 2]
Phase II trial update for MEDI4736 (durvalumab) in combination with chemotherapy as first-line treatment for unresectable mesothelioma; stud…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-08-25Clinical Trial Update: Trimodal Lung-Sparing Treatment of Pleural Mesothelioma [Phase 2]
Phase 2 trial update on trimodal, lung-sparing treatment for pleural mesothelioma; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma [Phase 2]
This Phase 2 randomized, double-blind study compares tremelimumab to placebo in unresectable malignant mesothelioma, with results posted in …
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma [Phase 2]
Phase 2 trial evaluating pemetrexed plus cisplatin followed by surgery and radiation for mesothelioma was terminated.
-
CLINICAL_TRIALS trial_result · 2016-10-24Clinical Trial Update: Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma [Phase 2]
A Phase 2 trial of tivantinib in previously treated malignant mesothelioma was terminated, with results posted in 2016.
-
CLINICAL_TRIALS research · 2015-10-27Clinical Trial Update: A Study of Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1) [Phase 2]
Phase 2 clinical trial update on Tremelimumab combined with the anti-PD-L1 antibody durvalumab (MEDI4736) for malignant mesothelioma, includ…
-
CLINICAL_TRIALS trial_result · 2013-05-14Clinical Trial Update: Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy [Phase 2]
Phase II trial evaluating IMC-A12 in mesothelioma patients who had prior chemotherapy has completed, with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2012-03-19Clinical Trial Update: Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung Cancer [Phase 1, Phase 2]
A Phase I/II trial of PTK787 with pemetrexed, with or without cisplatin, for non-small cell lung cancer and pleural mesothelioma has been te…